SR ONE CAPITAL MANAGEMENT, LP Q1 2023 Filing

Filed May 9, 2023

Portfolio Value

$240.4B

Holdings

5

Report Date

Q1 2023

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
ACLXARCELLX INC.
5,500,007$169.5B70.50%
2
DSGNDESIGN THERAPEUTICS INC
6,526,476$37.7B15.67%
3
SPRYARS PHARMACEUTICALS
4,012,903$26.1B10.87%
4
NKTXNKARTA INC.
1,333,333$4.7B1.97%
5
EFTREFFECTOR THERAPEUTICS INC
6,822,114$2.4B0.99%